Stay updated on Factor IX Gene Therapy in Severe Hemophilia B Clinical Trial
Sign up to get notified when there's something new on the Factor IX Gene Therapy in Severe Hemophilia B Clinical Trial page.

Latest updates to the Factor IX Gene Therapy in Severe Hemophilia B Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.0%
- Check15 days agoChange DetectedThe study has reduced its locations from 64 to 60, with specific locations in Brisbane, Queensland, and several international sites being removed. Additionally, new dates have been added for the study.SummaryDifference3%
- Check23 days agoChange DetectedThe page has undergone significant changes, including the removal of detailed information about a clinical study evaluating a gene therapy for hemophilia B, while a new registry identifier and version revision have been added.SummaryDifference12%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.0%
- Check37 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.0%
- Check66 days agoChange DetectedThe webpage has removed a notice regarding heavy traffic affecting NLM-NCBI services and a link to obtain contact information for a study center provided by Pfizer.SummaryDifference1%
Stay in the know with updates to Factor IX Gene Therapy in Severe Hemophilia B Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Factor IX Gene Therapy in Severe Hemophilia B Clinical Trial page.